Skip to main content

FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline

News


Abstract

In a historic first for the agency, FDA Commissioner Martin A. Makary, M.D., M.P.H., today announced an aggressive timeline to scale use of artificial intelligence (Al) internally across all FDA centers by June 30, 2025, following the completion of a new generative Al pilot for scientific reviewers.
Key Data

  • Publication Date
    08 May 2025
  • Primary Author
    Martin A. Makary
  • Source
    FDA
  • Language
    English
Click below to visit original source: